Skip to main content
Close

Head & Neck

Protocols

Nasopharyngeal Carcinoma

Locally Advanced Disease

HNNLAPG

Induction Treatment of Locally Advanced Nasopharyngeal Cancer with CISplatin and Gemitabine


HNNLAPRT

Treatment of Locally Advanced Nasopharyngeal Cancer with Concurrent CISplatin and Radiation


Advanced Disease

HNNAVFUFA

5-Fluorouracil and Leucovorin for Recurrent Head and Neck Cancer (Nasopharyngeal)


HNNAVFUP

Treatment for Advanced Nasopharyngeal Cancer of the Head and Neck usingPlatinum and Fluorouracil


HNNAVGEM

Treatment of Loco-regionally Recurrent/Metastatic Nasopharyngeal Cancer Not Amenable for Local Curative Therapy with Gemcitabine


HNNAVP

Palliative Chemotherapy for Advanced Head and Neck Nasopharyngeal Carcinoma with Weekly CISplatin


HNNAVPE

Treatment of Recurrent and/or MetastaticNasopharyngeal Cancer with Platinum and Etoposide


HNNAVPG

Treatment of Locoregionally Recurrent and/or Metastatic Nasopharyngeal Cancer with Platinum and Gemcitabine


HNNAVCAP

Treatment Of Recurrent Or Metastatic Nasopharyngeal Cancer With Capecitabine

HNNAVPC

Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma with CARBOplatin and PACLitaxel

Squamous Cell Carcinoma

Locally Advanced Disease

HNLAALTPRT

Treatment of Locally Advanced (Alternate) Head and Neck Cancer Using CISplatin during Radiation Therapy


HNLAPRT

Combined Chemotherapy (CISplatin) and Radiation Treatment for Locally Advanced Squamous Cell Carcinoma of The Head and Neck


HNLACAFRT

Combined Chemotherapy (CARBOplatin and Fluorouracil) and Radiation Treatment for Locally Advanced Squamous Cell Carcinoma of the Head and Neck


HNLACETRT

Combined Cetuximab and Radiation Treatment for Locally Advanced Squamous Cell Carcinoma of the Head and Neck


UHNLADCF

Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck with DOCEtaxel, CISplatin and Infusional Fluorouracil


Advanced Disease

HNAVDOC

Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck with DOCEtaxel


HNAVFUP

Treatment of Advanced Squamous Cell Carcinoma of the Head and Neck Cancer Using Fluorouracil and Platinum


HNAVFUFA

5-Fluorouracil and Leucovorin for Recurrent Head and Neck Cancer (Squamous Cell Carcinoma)


HNAVM

Treatment of Head and Neck Cancer Using Methotrexate as Standard Therapy


HNAVP

Palliative Chemotherapy for Advanced Head and Neck Squamous Cell Carcinoma with Weekly CISplatin


HNAVPD

Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck with Platinum and DOCEtaxel


HNAVPE

Treatment of Recurrent and Metastatic Squamous Cell Cancer with Platinum and Etoposide

Other 

HNOTAMIRT

Radioprotection in Head and Neck Radiation using Amifostine


HNOTAVD

Palliative Therapy for Advanced Thyroid Cancers Using DOXOrubicin


UHNOTLEN

Therapy for Locally Recurrent or Metastatic, RAI-refractory Differentiated Thyroid Cancer Using Lenvatinib


HNOTTSH

Radioiodine Imaging in Patients with Thyroid Cancer using Thyrotropin Alpha

Salivary Tumours

HNSAVFAC

Palliative Therapy for Advanced Salivary Gland Cancers Using Cyclophosphamide, DOXOrubicin and Fluorouracil


HNSAVFUP

Treatment of Advanced Head and Neck Cancer Using CISplatin and Fluorouracil


HNSAVNP

Treatment of Advanced Salivary Gland Cancers With CISplatin and Vinorelbine


HNSAVPAC

Treatment of Advanced Salivary Gland Cancers With Platinum, DOXOrubicin and Cyclophosphamide


HNSAVTAM

Treatment of Recurrent/Metastatic Salivary Gland Cancers of the Head and Neck With Tamoxifen

Terms of use

The information contained in these documents is a statement of consensus of BC Cancer Agency professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. Use of these documents is at your own risk and is subject to BC Cancer Agency's terms of use.

Tab Heading
Tab Heading
SOURCE: Head & Neck ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Cancer Agency. All Rights Reserved.

    Copyright © 2017 Provincial Health Services Authority